Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Tenaya Therapeutics Inc (NASDAQ: TNYA) closed the day trading at $0.46 down -3.19% from the previous closing price of $0.47. In other words, the price has decreased by -$3.19 from its previous closing price. On the day, 2.39 million shares were traded.
Ratios:
For a better understanding of TNYA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.27 and its Current Ratio is at 5.27. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.10.
On November 30, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’25 when COLUMN GROUP III GP, LP bought 35,714,284 shares for $0.70 per share. The transaction valued at 24,999,999 led to the insider holds 49,313,559 shares of the business.
GOEDDEL DAVID V bought 35,714,284 shares of TNYA for $24,999,999 on Mar 05 ’25. The Director now owns 49,313,559 shares after completing the transaction at $0.70 per share. On Nov 18 ’24, another insider, Saito Chihiro, who serves as the SVP, Accounting and Fin. Ops. of the company, sold 2,258 shares for $2.12 each. As a result, the insider received 4,787 and left with 60,983 shares of the company.
Stock Price History:
Over the past 52 weeks, TNYA has reached a high of $6.78, while it has fallen to a 52-week low of $0.39. The 50-Day Moving Average of the stock is -60.85%, while the 200-Day Moving Average is calculated to be -80.88%.
Shares Statistics:
A total of 154.22M shares are outstanding, with a floating share count of 127.16M. Insiders hold about 17.55% of the company’s shares, while institutions hold 21.34% stake in the company.
Earnings Estimates
The dynamic stock of Tenaya Therapeutics Inc (TNYA) is currently being evaluated by a team of 8.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.3 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$1.11 and -$1.39 for the fiscal current year, implying an average EPS of -$1.33. EPS for the following year is -$1.17, with 7.0 analysts recommending between -$0.72 and -$1.42.
